Biofrontera Inc (BFRI)

Jun 18, 2025

Biofrontera Holds Annual Stockholders Meeting, Key Decisions Made - TipRanks

Jun 18, 2025

Jun 18, 2025

Biofrontera AG Extends Payment Deferral Amid Ongoing Negotiations - TipRanks

Jun 18, 2025

Jun 15, 2025

Short Interest in Biofrontera Inc. (NASDAQ:BFRI) Increases By 74.8% - Defense World

Jun 15, 2025

Jun 12, 2025

Biofrontera Inc. (BFRI) Engages in Strategic Talks with Biofront - GuruFocus

Jun 12, 2025

Jun 11, 2025

Biofrontera Inc. Confirms Talks on Merger, Licensing Changes with Biofrontera AG - MarketScreener

Jun 11, 2025

Jun 11, 2025

Biofrontera Inc. Negotiates Cooperation Changes with Biofrontera AG - TipRanks

Jun 11, 2025

Jun 11, 2025

Biofrontera in talks with AG parent for possible merger or deal terms - Investing.com India

Jun 11, 2025

Jun 11, 2025

Biofrontera Inc. Confirms Negotiations for Potential Combination with Biofrontera AG - Nasdaq

Jun 11, 2025

Jun 11, 2025

Biofrontera in talks with AG parent for possible merger or deal terms By Investing.com - Investing.com South Africa

Jun 11, 2025

Jun 11, 2025

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG - GlobeNewswire

Jun 11, 2025

Jun 11, 2025

National Crime Prevention Council Urges McDonald's to End Snapchat Partnership Over Child Safety Concerns - The Manila Times

Jun 11, 2025

Jun 11, 2025

Biofrontera Inc Explores Merger with Parent Company, Major US License Agreement Changes on Table - Stock Titan

Jun 11, 2025

Jun 10, 2025

Biofrontera AG Explores Strategic Changes with Biofrontera Inc. - TipRanks

Jun 10, 2025

Jun 05, 2025

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update - mx.advfn.com

Jun 05, 2025

Jun 05, 2025

Actinic Keratosis Treatment Market SWOT Analysis by Leading Expert: Almirall, Biofrontera, Nestle - newstrail.com

Jun 05, 2025

Jun 04, 2025

Biofrontera secures patent for Ameluz formulation until 2043 By Investing.com - Investing.com South Africa

Jun 04, 2025

Jun 03, 2025

biofrontera inc. revises proxy statement disclosure By Investing.com - Investing.com South Africa

Jun 03, 2025

Jun 03, 2025

biofrontera inc. revises proxy statement disclosure - Investing.com

Jun 03, 2025

Jun 03, 2025

Biofrontera Updates Proxy Statement for 2025 Meeting - TipRanks

Jun 03, 2025

Jun 03, 2025

Biofrontera Glycol-Free Skin Gel Added to FDA 'Orange Book;' Shares Rise - marketscreener.com

Jun 03, 2025

Jun 03, 2025

Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA R - GuruFocus

Jun 03, 2025

Jun 03, 2025

Biofrontera Inc. (BFRI) Propylene Glycol-Free Patent Gains FDA Recognition | BFRI Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Biofrontera secures patent for Ameluz formulation until 2043 - Investing.com

Jun 03, 2025

Jun 03, 2025

Biofrontera announces inclusion of patent in FDA Orange Book - TipRanks

Jun 03, 2025

Jun 03, 2025

Biofrontera Inc. Announces Patent for Propylene Glycol-Free - GlobeNewswire

Jun 03, 2025

Jun 03, 2025

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book - Yahoo Finance

Jun 03, 2025

May 31, 2025

Biofrontera stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa

May 31, 2025

May 30, 2025

Biofrontera stock hits 52-week low at $0.58 amid market challenges - Investing.com India

May 30, 2025

May 27, 2025

Biofrontera AG Faces Financial Uncertainty Amid Biofrontera Inc. Payment Issues - TipRanks

May 27, 2025

May 23, 2025

Biofrontera Receives Nasdaq Non-Compliance Notice - TipRanks

May 23, 2025

May 22, 2025

Roth Capital Decreases Earnings Estimates for Biofrontera - Defense World

May 22, 2025

May 22, 2025

Q2 Earnings Forecast for Biofrontera Issued By Roth Capital - Defense World

May 22, 2025

May 20, 2025

Biofrontera Inc. (NASDAQ:BFRI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 20, 2025

May 20, 2025

Biofrontera (NASDAQ:BFRI) Price Target Lowered to $2.75 at Benchmark - Defense World

May 20, 2025

May 19, 2025

Biofrontera, Inc. Earnings Call: Growth Amid Challenges - TipRanks

May 19, 2025

May 19, 2025

Benchmark cuts Biofrontera stock target to $2.75, keeps Buy rating By Investing.com - Investing.com Nigeria

May 19, 2025

May 19, 2025

Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com - FinancialContent

May 19, 2025

May 19, 2025

Biofrontera (BFRI) Sees Price Target Reduction by Benchmark | BF - GuruFocus

May 19, 2025

May 19, 2025

Benchmark cuts Biofrontera stock target to $2.75, keeps Buy rating - Investing.com Australia

May 19, 2025

May 19, 2025

Biofrontera (BFRI) Target Price Trimmed After Lower Revenue Perf - GuruFocus

May 19, 2025

May 19, 2025

Biofrontera Inc. price target lowered to $2.75 from $7 at Benchmark - TipRanks

May 19, 2025

May 19, 2025

Biofrontera signals 2025 record revenue ambitions with new Ameluz patent and cost controls - MSN

May 19, 2025

May 17, 2025

Biofrontera Inc. (BFRI) Reports 9% Revenue Growth in Q1 2025 - GuruFocus

May 17, 2025

May 16, 2025

Earnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dips - Investing.com Nigeria

May 16, 2025

May 16, 2025

Earnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dips By Investing.com - Investing.com South Africa

May 16, 2025

May 16, 2025

Transcript : Biofrontera Inc., Q1 2025 Earnings Call, May 16, 2025 - marketscreener.com

May 16, 2025